Immunotoxins for in Vivo Therapy: Where Are We?
- 1 December 1987
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 507 (1) , 155-167
- https://doi.org/10.1111/j.1749-6632.1987.tb45798.x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Development of an Immunotoxin with in Vivo Efficacy for Murine SystemsAnnals of the New York Academy of Sciences, 1987
- Kinetic comparison of ricin immunotoxins: biricin conjugate has potentiated cytotoxicityBiochemistry, 1986
- TRANSMEMBRANE TRANSPORT OF DIPHTHERIA TOXIN, RELATED TOXINS, AND COLICINSAnnual Review of Biochemistry, 1986
- Effects of therapy with T101 ricin A-chain immunotoxin in two leukemia patientsBlood, 1986
- Anti-T-Cell Reagents for Human Bone Marrow Transplantation: Ricin Linked to Three Monoclonal AntibodiesScience, 1983
- Monensin blocks the transport of diphtheria toxin to the cell cytoplasm.The Journal of cell biology, 1982
- Studies on the galactose-binding site of ricin and the hybrid toxin man6P-ricinCell, 1981
- Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.Proceedings of the National Academy of Sciences, 1980
- Antibodies introduced into living cells by red cell ghosts are functionally stable in the cytoplasm of the cellsCell, 1979
- Binding of triton X-100 to diphtheria toxin, crossreacting material 45, and their fragments.Proceedings of the National Academy of Sciences, 1976